🎉 Share Your 2025 Year-End Summary & Win $10,000 Sharing Rewards!
Reflect on your year with Gate and share your report on Square for a chance to win $10,000!
👇 How to Join:
1️⃣ Click to check your Year-End Summary: https://www.gate.com/competition/your-year-in-review-2025
2️⃣ After viewing, share it on social media or Gate Square using the "Share" button
3️⃣ Invite friends to like, comment, and share. More interactions, higher chances of winning!
🎁 Generous Prizes:
1️⃣ Daily Lucky Winner: 1 winner per day gets $30 GT, a branded hoodie, and a Gate × Red Bull tumbler
2️⃣ Lucky Share Draw: 10
Hims & Hers Health Unveils $250 Million Stock Buyback Initiative, Signaling Confidence in Valuation
Hims & Hers Health, Inc. (HIMS) has announced a substantial new share repurchase initiative targeting up to $250 million in Class A common stock, to be executed over the coming three years. This latest move comes on the heels of the company’s full drawdown of its preceding $100 million buyback program, which commenced in July 2024.
The latest authorization demonstrates management’s conviction regarding current market conditions. Company leadership believes the present trading valuation may not adequately capture the underlying value of the enterprise, positioning the buyback as a strategic capital deployment opportunity.
In pre-market activity on the New York Stock Exchange, HIMS shares reflected positive momentum, trading at $36.98, up 0.11% from the prior close. The consecutive authorization of large-scale repurchase programs underscores Hims & Hers Health’s confidence in its business trajectory and commitment to enhancing shareholder value through opportunistic capital management.
The recurring buyback authorizations illustrate how the company is allocating its financial resources and reinforces investor sentiment regarding growth potential and operational execution within the health and wellness sector.